Transient myeloproliferative disease

Transient myeloproliferative disease (TMD) is a condition that affects the blood cells of newborn infants. It is characterized by an overproduction of immature white blood cells, called blast cells, which can lead to various health problems. TMD is often associated with Down syndrome, and it is sometimes referred to as transient leukemia.

Symptoms

The symptoms of TMD can vary greatly from one infant to another. Some infants may show no symptoms at all, while others may experience:

• Jaundice
• Anemia
• Thrombocytopenia (low platelet count)
• Hepatosplenomegaly (enlarged liver and spleen)
• Respiratory distress
• Skin rash

Causes

TMD is caused by a mutation in the GATA1 gene. This mutation leads to the overproduction of blast cells. The exact reason why this mutation occurs is not yet fully understood.

Diagnosis

Diagnosis of TMD is usually made through a blood test or bone marrow biopsy. These tests can reveal the presence of an unusually high number of blast cells.

Treatment

Treatment for TMD often involves supportive care, such as blood transfusions to treat anemia and thrombocytopenia. In some cases, chemotherapy may be used to reduce the number of blast cells. Most infants with TMD recover without treatment within three months.

Prognosis

The prognosis for infants with TMD is generally good. Most infants recover without treatment within three months. However, infants with TMD have a higher risk of developing acute myeloid leukemia (AML) later in life.

See also

• Down syndrome
• Acute myeloid leukemia
• Blood disorders in children

Transient myeloproliferative disease Resources
Latest articles Most recent articles Ongoing trials	Wikipedia